Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)
|
May 22, 2024
Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice
Hugo Geerts, Silke Bergeler, Mike Walker, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 9, 2022
A quantitative systems pharmacology model for simulating OFF-Time in augmentation trials for Parkinson's disease: application to preladenant
Rachel Rose, Emma Mitchell, Piet Van Der Graaf, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 29, 2025
Interactions of Therapeutic Antibodies With Presynaptically-Released Misfolded Proteins in Neurodegenerative Diseases. A Spatial Monte-Carlo Simulation Study
Jamie Goff, Maryam Khalifa, Shaina M Short, et al.
Scientific Reports
|
September 1, 2023
Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model
Hugo Geerts, Silke Bergeler, Mike Walker, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 21, 2018
Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare
Giouliana Kadra, Athan Spiros, Hitesh Shetty, et al.
Proteomics
|
July 12, 2002
Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice
Kelly Tilleman, Chris Van den Haute, Hugo Geerts, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 15, 2021
Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies
Peter Bloomingdale, Tatiana Karelina, Murat Cirit, et al.
Journal of Alzheimer'S Disease : JAD
|
June 4, 2019
Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective
Harald Hampel, Simone Lista, Dalila Mango, et al.
Alzheimer Disease and Associated Disorders
|
December 6, 2005
Neuroprotection and neurodegenerative diseases: from biology to clinical practice
Yvette Akwa, Hervé Allain, Danièle Bentue-Ferrer, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 3, 2002
Neuropathobiology in transgenic mice. The case of Alzheimer's disease
Jo Van Dorpe, Kurt Spittaels, Chris Van Van den Haute, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Alzheimer'S & Dementia (New York, N. Y.)
|
May 22, 2024
Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice
Hugo Geerts, Silke Bergeler, Mike Walker, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 9, 2022
A quantitative systems pharmacology model for simulating OFF-Time in augmentation trials for Parkinson's disease: application to preladenant
Rachel Rose, Emma Mitchell, Piet Van Der Graaf, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 29, 2025
Interactions of Therapeutic Antibodies With Presynaptically-Released Misfolded Proteins in Neurodegenerative Diseases. A Spatial Monte-Carlo Simulation Study
Jamie Goff, Maryam Khalifa, Shaina M Short, et al.
Scientific Reports
|
September 1, 2023
Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model
Hugo Geerts, Silke Bergeler, Mike Walker, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 21, 2018
Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare
Giouliana Kadra, Athan Spiros, Hitesh Shetty, et al.
Proteomics
|
July 12, 2002
Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice
Kelly Tilleman, Chris Van den Haute, Hugo Geerts, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 15, 2021
Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies
Peter Bloomingdale, Tatiana Karelina, Murat Cirit, et al.
Journal of Alzheimer'S Disease : JAD
|
June 4, 2019
Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective
Harald Hampel, Simone Lista, Dalila Mango, et al.
Alzheimer Disease and Associated Disorders
|
December 6, 2005
Neuroprotection and neurodegenerative diseases: from biology to clinical practice
Yvette Akwa, Hervé Allain, Danièle Bentue-Ferrer, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 3, 2002
Neuropathobiology in transgenic mice. The case of Alzheimer's disease
Jo Van Dorpe, Kurt Spittaels, Chris Van Van den Haute, et al.
Page
of 8